Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: A potential role in the modulation of Ige synthesis

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4622-4627

  Jirapongsananuruk, Orathai ^a   Hofer, Michaël F ^a   Trumble, Anne E ^a   Norris, David A ^b   Leung, Donald Y M ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; HEAT SHOCK PROTEIN; INTERLEUKIN 4;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DATA ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN ALLERGY;

ADULT; ANTIGENS, CD; ANTIGENS, CD86; B-LYMPHOCYTES; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-4;

EID: 0032080395     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Leung, D. Y. M. 1993. The immunology of atopic dermatitis. Curr. Opin. Immunol. 5:956.
2. Jenkins, M. K., E. Burrell, and J. D. Ashwell. 1990. Antigen presentation by resting B cells: effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. J. Immunol. 144:1585.
3. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
4. Vercelli, D., H. H. Jabara, K. Arai, and R. S. Geha. 1989. Induction of human IgE synthesis requires interleukin 4 and T-B cell interaction involving the T cell receptor/CD3 complex and MHC class Il antigens. J. Exp. Med. 169:1295.
5. + T cell responses. Immunol. Today 17:410.
6. Geha, R. S. 1992. Regulation of IgE synthesis in humans. J. Allergy Clin. Immunol. 90:143.
7. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
8. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
9. Linsley, P. S., J. A. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7.1 and B7.2 bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
10. Ellis, J. H., M. N. Burden, D. V. Vinogradov, C. Linge, and J. S. Crowe. 1996. Interactions of CD80 and CD86 with CD28 and CTLA-4. J. Immunol. 56:2700.
11. Morton, P. A., X. T. Fu, J. A. Stewart, K. S. Giacoletto, S. L. White, C. E. Leysath, R. J. Evans, J. J. Shieh, and R. W. Karr. 1996. Differential effects of CTLA-4 substitution on the binding of human CD80 (B7.1 ) and CD86 (B7.2). J. Immunol. 156:1047.
12. Kariv, I., A. Truneh, and R. W. Sweet. 1996. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J. Immunol. 157:29.
13. H-2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
14. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X. Y. Ke, P. D. Rennen, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
15. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and A. Azuma. 1995. CD80 and CD86 provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
16. Natesan, M., Z. Razi-Wolf, and H. Reiser. 1996. Costimulation of IL-4 production by murine B7.1 and B7.2 molecules. J. Immunol. 156:2783.
17. Haninn, J. 1982. Atopic dermatitis. J. Am. Acad. Dermatol. 6:1.
18. Leung, D. Y. M. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96:302.
19. Bujanowski-Weber, J., B. Bring, I. Knoller, T. Pfeil, and W. Konig. 1989. Expression of low affinity receptor for IgE (Fc epsilon R II, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B cell line RPMI-8866 and human peripheral lymphocyte of normal and atopic donors. Immunology 66:505.
20. Van der Heijden, F. L., R. J. Joost van Neerven, M. van Katwijk, J. D. Bos, and M. L. Kapsenberg. 1993. Serum IgE facilitated allergen presentation in atopic disease. J. Immunol. 150:3643.
21. Renz, H., K. Jujo, K. L. Bradley, J. Domenico, E. W. Gelfand, and D. Y. M. Leung. 1992. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J. Invest. Dermatol. 99:403.
22. Jujo, K., H. Renz, J. Abe, E. W. Gelfand, and D. Y. M. Leung. 1992. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J. Allergy Clin. Immunol. 90:323.
23. Hamid, Q., M. Boguniewicz, and D. Y. M. Leung. 1994. Differential cytokine gene expression in acute vs chronic atopic dermatitis. J. Clin. Invest. 94:870.
24. Hamid, Q., T. Naseer, E. M. Minshall, T. L. Song, M. Boguniewicz, and D. Y. M. Leung. 1996. In vivo expression of interleukin-12 and interleukin-13 in atopic dermatitis. J. Allergy Clin. Immunol. 98:225.
25. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 97:389.
26. H2 phenotype in patients with atopic dermatitis. J. Allergy Clin. Immunol. 90:184.
27. Uyemura, K., M. Yamamura, D. F. Fivenson, R. L. Modlin, and B. J. Nicholoff. 1993. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101:701.
28. H-1 subset. J. Invest. Dermatol. 102:145.
29. Funderud, S., K. Nustad, and T. Lea. 1987. Fractionation of lymphocytes by immunomagnetic beads. In Lymphocytes: A Practical Approach. G. G. B. Klaus, ed. Oxford University Press, New York, p. 55.
30. Leung, D. Y. M., M. Gately, A. Trumble, B. Ferguson-Darnell, P. M. Schlievert, and L. J. Picker. 1995. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J. Exp. Med. 181:747.
31. Hofer, M. F., M. R. Lester, P. M. Schlievert, and D. Y. M. Leung. 1995. Effect of bacterial toxins on IgE synthesis. Clin. Exp. Allergy 25:1218.
32. Yssel, H., J. E. deVries, M. Koken, W. V. Blitterswijk, and H. Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72:219.
33. Jujo, K., H. Renz, J. Abe, A. Trumble, E. W. Gelfand, and D. Y. M. Leung. 1993. Pokeweed mitogen induces IgE synthesis in the presence of a blocking antibody to the interferon-gamma receptor. J. Allergy Clin. Immunol. 91:1206.
34. Cause, W. C., M. J. Halvorson, P. Lu, R. Greenwald, P. Linsley, J. F. Urban, and F. D. Finkelman. 1997. The function of costimulatory molecules and the development of IL-4 producing T cells. Immunol. Today 18:115.
35. Pène, J. 1989. Regulatory role of cytokines and CD23 in human IgE antibody synthesis. Im. Arch. Allergy Appl. Immunol. 90:32.
36. Zhang, K., E. A. Clark, and A. Saxon. 1991. CD40 stimulation provides an IFN-γ independent and IL-4 dependent differentiation signal directly to human B cells for IgE production. J. Immunol. 146:1836.
37. Life, P., J. P. Aubry, S. Estoppey, V. Schnuriger, and J. Y. Bonnefoy. 1995. CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis. Eur. J. Immunol. 25:333.
38. Cause, W. C., S. J. Chen, R. J. Greenwald, M. J. Halvorson, P. Liu, X. D. Zhou, S. C. Morris, K. P. Lee, C. H. June, F. D. Finkelman, J. F. Urban, and R. Abe, 1997. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:4082.
39. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle. 1997. Costimulation through B7.2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airway hyperresponsiveness. J. Exp. Med. 185:1671.
40. Hofer, M. F., O. Jirapongsananurvk, A. E. Trumble, D. Y. M. Leung. Upregulation of B7.2, but not B7-1, on B cells from patients with allergic asthma. J. Allergy Clin. Immunol. 101:96.
41. Renz, H., K. Jujo, K. L. Bradley, J. Domenico, E. W. Gelfand, and D. Y. M. Leung. 1992. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J. Invest. Dermatol. 99:403.
42. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependenl T cell activation requirement of B7-CD28 signaling through CD40. Science 273:1862.
43. Hasbold, J., C. Johnson-Leger, C. J. Atkins, E. A. Clark, and G. G. B. Klaus. 1994. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24:1835.
44. Paterson, R. L. K., G. Lack, J. M. Domenico, G. Delespesse, D. Y. M. Leung, T. H. Finkel, and E. W. Gelfand. 1996. Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease. Eur. J. Immunol 26:1979.
45. Siepmann, K., G. Wohlleben, and D. Gray. 1996. CD40-mediated regulation of interleukin-4 signaling pathways in B lymphocytes. Eur. J. Immunol. 26:1544.
46. Lu, P., J. F. Urban, X. D. Zhou, S. J. Chen, K. Madden, M. Moorman, H. Nguyen, S. C. Morris, F. D. Finkelman, and W. C. Cause. 1996. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production. J. Immunol. 156:3327.
47. de Boer, M., A. Kasran, J. Kwekkeboom, H. Walter, P. Vandenberghe, and J. L. Ceuppens. 1993. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120.
48. Defrances, T., J. P. Aubry, F. Rousset, B. Vanbervliet, J. Y. Bonnefoy, N. Arou, Y. Takebe, T. Yokota, F. Lee, K. Arai, J. deVries, and J. Banchereau. 1987. Human recombinant imerleukin 4 induces Fee receptors (CD23) on normal B lymphocytes. J. Exp. Med. 165:1459.
49. + T cells to produce IL-4. J. Immunol. 158:4171.